Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of antipsychotics on functional candidate endophenotypes in schizophrenia
2008-002242-34Phase 4Terminated
- Sponsor
- Center for Neuropsychiatric Schizophrenia Research
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sertindole and risperidone in schizophrenia (2 arms), sponsored by Center for Neuropsychiatric Schizophrenia Research. Primary endpoints: Normalization of sensory gating during sertindole treatment and Lack of normalization of sensory gating during risperidone treatment. Started Jun 2008; status: terminated.
02
Drugs
sertindolerisperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2008-002242-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002242-34.